Steven Loeb speaks with Brent Vaughan, Chief Executive Officer at Cognito Therapeutics, a company developing novel disease modifying therapies for neurodegenerative diseases based on neuromodulation. 

Thanks you to our sponsors: Advsr; a boutique M&A advisory firm. They wrote the book on startup M&A called "Magic Box Paradigm: A framework for startup acquisitions." Also thanks to Stratpoint, an outsourced engineering firm and Scrubbed, an online bookkeeping firm. We highly recommend them!

Interview with Brent Vaughan, CEO of Cognito Therapeutics

Vator